Natacha Gassenbach
Public Communications Contact bei BIOGEN INC.
Aktive Positionen von Natacha Gassenbach
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOGEN INC. | Public Communications Contact | 01.10.2018 | - |
Karriereverlauf von Natacha Gassenbach
Ehemalige bekannte Positionen von Natacha Gassenbach
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| STALLERGENES GREER | Investor Relations Kontakt | - | 01.10.2018 |
| Public Communications Contact | - | 01.10.2018 | |
| BOSTON SCIENTIFIC CORPORATION | Public Communications Contact | - | - |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Public Communications Contact | - | - |
| BAXALTA INC | Public Communications Contact | - | - |
Ausbildung von Natacha Gassenbach
| Sorbonne Université | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 2 |
| Frankreich | 2 |
Operativ
| Public Communications Contact | 5 |
| Investor Relations Contact | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Stallergenes Greer Ltd.
 Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
- Börse
- Insiders
- Natacha Gassenbach
- Erfahrung